PURPOSE: This study aimed to evaluate patients' perceived receipt of information according to the possibility of cure in esophageal cancer. METHODS: One hundred and twelve consecutive patients presenting at the multidisciplinary visit at the Veneto Institute of Oncology for esophageal cancer between 2014 and 2016 were included in the study. The Italian version of the European Organization for Research and Treatment of Cancer (EORTC) quality of life questionnaires C30 (core questionnaire), OG25 (esophago-gastric cancer module), and INFO25 (information module) were used. RESULTS: Candidates for palliative treatment were less informed about the disease (adjusted mean difference - 11.5, 95% CI - 23.0 to - 0.02) and less satisfied with information provided (adjusted mean difference - 18.3, 95% CI - 31.9 to - 4.7) than candidates for curative treatment. In addition, candidates for palliative treatment wanted to receive more information than candidates for curative treatment (adjusted mean difference 26.1, 95% CI 0.5 to 51.6). Better quality of life was associated with satisfaction of received information (β = 0.77, p < 0.0001) and of receiving information about things that the patient can do to help himself (β = 0.26, p = 0.04). More anxiety was associated to receiving more information about disease (β = 0.46, p = 0.02) but less information about things that the patient can do to help himself (β = - 0.38, p = 0.02). CONCLUSIONS: Candidates for palliative treatment were less satisfied with information about the disease and wanted to receive more information. Additionally, some aspects of quality of life were found to be associated with perceived receipt of information. Appropriate training in communication of prognostic information may improve clinical management of incurable cancer patients.
PURPOSE: This study aimed to evaluate patients' perceived receipt of information according to the possibility of cure in esophageal cancer. METHODS: One hundred and twelve consecutive patients presenting at the multidisciplinary visit at the Veneto Institute of Oncology for esophageal cancer between 2014 and 2016 were included in the study. The Italian version of the European Organization for Research and Treatment of Cancer (EORTC) quality of life questionnaires C30 (core questionnaire), OG25 (esophago-gastric cancer module), and INFO25 (information module) were used. RESULTS: Candidates for palliative treatment were less informed about the disease (adjusted mean difference - 11.5, 95% CI - 23.0 to - 0.02) and less satisfied with information provided (adjusted mean difference - 18.3, 95% CI - 31.9 to - 4.7) than candidates for curative treatment. In addition, candidates for palliative treatment wanted to receive more information than candidates for curative treatment (adjusted mean difference 26.1, 95% CI 0.5 to 51.6). Better quality of life was associated with satisfaction of received information (β = 0.77, p < 0.0001) and of receiving information about things that the patient can do to help himself (β = 0.26, p = 0.04). More anxiety was associated to receiving more information about disease (β = 0.46, p = 0.02) but less information about things that the patient can do to help himself (β = - 0.38, p = 0.02). CONCLUSIONS: Candidates for palliative treatment were less satisfied with information about the disease and wanted to receive more information. Additionally, some aspects of quality of life were found to be associated with perceived receipt of information. Appropriate training in communication of prognostic information may improve clinical management of incurable cancerpatients.
Entities:
Keywords:
Cancer management; Communication; Esophageal cancer; Information; Quality of life
Authors: Olga Husson; Melissa S Y Thong; Floortje Mols; Simone Oerlemans; Adrian A Kaptein; Lonneke V van de Poll-Franse Journal: Psychooncology Date: 2012-02-06 Impact factor: 3.894
Authors: Juan Ignacio Arraras; Eva Greimel; Orhan Sezer; Wei-Chu Chie; Mia Bergenmar; Anna Costantini; Teresa Young; Karin Kuljanic Vlasic; Galina Velikova Journal: Eur J Cancer Date: 2010-07-30 Impact factor: 9.162
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: Pernilla Lagergren; Peter Fayers; Thierry Conroy; Hubert J Stein; Orhan Sezer; Richard Hardwick; Eva Hammerlid; Andrew Bottomley; Eric Van Cutsem; Jane M Blazeby Journal: Eur J Cancer Date: 2007-08-15 Impact factor: 9.162
Authors: J M Blazeby; R Macefield; N S Blencowe; M Jacobs; A G K McNair; M Sprangers; S T Brookes Journal: Br J Surg Date: 2015-05-18 Impact factor: 6.939
Authors: Angus G K McNair; F MacKichan; J L Donovan; S T Brookes; K N L Avery; S M Griffin; T Crosby; J M Blazeby Journal: BMC Cancer Date: 2016-03-31 Impact factor: 4.430
Authors: Luca M Saadeh; Annelijn E Slaman; Eleonora Pinto; Suzanne S Gisbertz; Francesco Cavallin; Egle Jezerskyte; Rita Alfieri; Loes Noteboom; Maria Cristina Bellissimo; Matteo Cagol; Giovanni Pirozzolo; Carlo Castoro; Marco Scarpa; Mark I van Berge Henegouwen Journal: J Thorac Dis Date: 2018-08 Impact factor: 2.895